Filing Details
- Accession Number:
- 0001104659-24-108373
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-15 08:30:16
- Reporting Period:
- 2024-10-10
- Accepted Time:
- 2024-10-15 08:30:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1781983 | Aprea Therapeutics Inc. | APRE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1716213 | P. John Hamill | 3805 Old Easton Road Doylestown PA 18902 | Srvp/Cfo/Prin Fin & Acct Ofcr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-10 | 450 | $2.61 | 19,318 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.55 to $2.618, inclusive. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Billionaire Hedge Funds
